Sartorius BIA Separations, Exopharm team for large-scale exosome production
Bio-chromatography company Sartorius BIA Separations and medicine biopharmaceutical company Exopharm have signed a material transfer agreement in order to meet the demand of improved large-scale therapeutic exosome production and commercialization. Read More
NSF grant awarded to develop membrane purification platform
University of Kentucky researchers, in collaboration with the University of Arkansas and Clemson University, have received a $1.6 million National Science Foundation (NSF) grant to create a membrane purification platform for large-scale biomanufacturing of viral vectors and virus-like particles. Read More
Researchers slash time needed to produce CAR T cells for cancer patients in need
Researchers at University Hospitals Seidman Cancer Center and their collaborators have streamlined the production of CAR T cells, a mainstay of modern immunotherapy treatment for certain cancers. Read More
Cytiva acquires Cevec Pharmaceuticals to boost cell line development
Life sciences company Cytiva has acquired Cevec Pharmaceuticals for an undisclosed amount, which will further strengthen Cytiva's cell line development, according to the companies. Read More
Stanford team synthesizes anticancer compound currently only sourced from rainforest tree
The synthesis of an anticancer compound in the laboratory by Stanford University researchers has cleared a barrier to the widespread use of a drug candidate that is currently extracted from a single plant species. Read More
PerkinElmer offers analysis platform for cell and gene therapy research, manufacturing
At the BioProcess International conference in Boston, PerkinElmer launched its new Cellaca PLX Image Cytometry System, which combines image cytometer hardware, software, validated consumables, and trackable data reporting -- all in one platform. Read More
Demand for viral vectors seen outpacing capacity growth despite investment surge
The growth in demand for viral vectors is outpacing a push to add capacity, leading to predictions that the current supply shortage will continue despite investment in the space. Read More
Federal funding of $2B to support biotechnology and biomanufacturing
The White House announced on Wednesday federal funding of more than $2 billion to advance President Joe Biden’s executive order intended to enable the U.S. to harness the full potential of biotechnology and biomanufacturing. Read More
Biden executive order launches National Biotechnology and Biomanufacturing Initiative
President Joe Biden signed an executive order today that is intended to allow the U.S. to harness the potential of biotechnology and biomanufacturing, according to an announcement by the White House. Read More
Akadeum looks to advance the cell separation process with microbubbles
Microbubble technology offers researchers the ability to perform cell separation without a column or magnet, generating higher yield and faster turnaround times, according to Akadeum Life Sciences CEO Brandon McNaughton who spoke with ScienceBoard.net about the company's technology. Read More
Conferences
Cell Bio 2022
December 3-7
District of Columbia United States
Glasgow International Health Festival
January 25-26, 2023
Glasgow
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter